Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-05-07
2000-09-26
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514278, 514318, 514326, 514330, 514331, 540524, 540597, 540598, 546 17, 546186, 546187, 546188, 546189, 546190, 546191, 546208, A61K 31445, C07D40102, C07D40114
Patent
active
061243167
ABSTRACT:
A compound of formula: ##STR1## in which: Ar represents a pyrid-2-yl or a phenyl which is unsubstituted or substituted by a halogen, a methyl or a (C.sub.1 -C.sub.4)alkoxy;
REFERENCES:
patent: 5340822 (1994-08-01), Emonds-Alt et al.
Maggi et al. "Tachykinin receptors and tachykinin recptor antagonists" J. Auton. Pharm. v. 13, p.23-93, 1993.
Bichon Daniel
Broeck Didier Van
Emonds-Alt Xavier
Gueule Patrick
Proietto Vincenzo
Chang Ceila
Sanofi
LandOfFree
Compounds which are specific antagonists of the human NK3 recept does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds which are specific antagonists of the human NK3 recept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds which are specific antagonists of the human NK3 recept will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100544